NCT03977467 2025-08-27Atezolizumab and Tiragolumab in Patients With NSCLC or Advanced Solid Tumors Having Had Prior Treatment With a PD-1 InhibitorSCRI Development Innovations, LLCPhase 2 Completed46 enrolled 12 charts